Skip to main content
SpringerLink
Log in

Surveillance of Patients Following Primary Therapy

  • Chapter
  • First Online:
Breast Disease

  • 873 Accesses

Abstract

Regular and appropriate follow-up of patients after treatment for breast cancer is an important aspect of comprehensive care. Breast cancer survival has increased due to improvements of treatment, leading to a much higher long-term survival of women diagnosed with breast cancer. The primary purpose of follow-up is often regarded as the early detection of recurrence as well as the detection of second primary tumors along with long-term sequelae of breast cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.

    Article  Google Scholar 

  2. Rojas MP, Telaro E, Russo A, Fossati R, Confalonieri C, Liberati A. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2005;1:CD001768.

    Google Scholar 

  3. Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, et al. Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract. 1999;49:705–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al. Routine follow up of breast cancer in primary care: randomized trial. BMJ. 1996;313:665–9.

    Article  CAS  Google Scholar 

  5. Hollowell K, Olmsted CL, Richardson AS, Pittman HK, Bellin L, et al. American Society of Clinical Oncology-recommended surveillance and physician specialty among long term breast cancer survivors. Cancer. 2010;116:2090–8.

    PubMed  Google Scholar 

  6. Chalasani P, Downey L, Stopeck AT. Caring for the breast cancer survivor: a guide for primary care physicians. Am J Med. 2010;123:489–95.

    Article  Google Scholar 

  7. Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14:2738–46.

    Article  CAS  Google Scholar 

  8. Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ, et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer. 2005;41:2637–44.

    Article  CAS  Google Scholar 

  9. Haffty BG, Carter D, Flynn SD, Fischer DB, Brash DE, Simons J, et al. Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys. 1993;27:575–83.

    Article  CAS  Google Scholar 

  10. van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 1999;35:32–8.

    Article  Google Scholar 

  11. Francis M, Cakir B, Ung O, Gebski V, Boyages J. Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast cancer. Br J Surg. 1999;86:1556–62.

    Article  CAS  Google Scholar 

  12. Buist DS, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, Breast Cancer Surveillance Consortium, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010;124:863–73.

    Article  Google Scholar 

  13. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008;68:3108–14.

    Article  CAS  Google Scholar 

  14. Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, American Society of Clinical Oncology, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–7.

    Article  Google Scholar 

  15. de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol. 2004;22:4010–8.

    Article  Google Scholar 

  16. Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114:403–128. Hayes DF. Clinical practice. Follow-up of patients with early breast cancer. N Engl J Med. 2007;356:2505–13.

    Article  Google Scholar 

  17. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG committee opinion. No. 336: tamoxifen and uterine cancer. Obstet Gynecol. 2006;107:1475–8.

    Article  Google Scholar 

  18. Hayes DF. Clinical practice. Follow-up of patients with early breast cancer. N Engl J Med. 2007;14(356):2505–13.

    Article  Google Scholar 

  19. Deitcher SR, Gomes MP. The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review. Cancer. 2004;101:439–49.

    Article  Google Scholar 

  20. Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet. 2001;7(358):56–63.

    Article  Google Scholar 

  21. King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–6.

    Article  CAS  Google Scholar 

  22. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117–30.

    Article  CAS  Google Scholar 

  23. Fossland VS, Stroop JB, Schwartz RC, Kurtzman SH. Genetic issues in patients with breast cancer. Surg Oncol Clin N Am. 2009;18:53–71.

    Article  Google Scholar 

  24. The American Society of Breast Surgeon Position Statement on BRCA genetic testing for patients with and without breast cancer. 2012. https://www.breastsurgeons.org/statements/PDF_Statements/BRCA_Testing.pdf. Accessed 26 June 2014.

  25. Koibuchi Y, Lino Y, Takei H, Maemura M, Horiguchi J, Yo- Koe T, et al. The effect of mass screening by physical examination combined with regular breast self-examination on clinical stage and course of Japanese women with breast cancer. Oncol Rep. 1998;5:151–5.

    CAS  PubMed  Google Scholar 

  26. GIVIO (Interdisciplinary Group for Cancer Care Evaluation). Practice of breast self examination: disease extent at diagnosis and patterns of surgical care. A report from an Italian study. J Epidemiol Community Health. 1991;45:112–6.

    Article  Google Scholar 

  27. Yilmaz MH. Imaging and follow-up after breast reconstruction. J Breast Dis. 2012;1:81–4.

    Google Scholar 

  28. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6:CD001877.

    Google Scholar 

  29. Magnus MC, Ping M, Shen MM, Bourgeois J, Magnus JH. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39–49 years: a meta-analysis. J Womens Health (Larchmt). 2011;20:845–52.

    Article  Google Scholar 

  30. Kim SJ, Moon WK, Cho N, Chang JM. The detection of recurrent breast cancer in patients with a history of breast cancer surgery: comparison of clinical breast examination, mammography and ultrasonography. Acta Radiol. 2011;52(1):15–20.

    Article  Google Scholar 

  31. Gweon HM, Son EJ, Youk JH, Kim JA, Chung J. Value of the US BI-RADS final assessment following mastectomy: BI-RADS 4 and 5 lesions. Acta Radiol. 2012;53:255–60.

    Article  Google Scholar 

  32. Destounis S, Morgan R, Arieno A, Seifert P, Somerville P, Murphy P. A review of breast imaging following mastectomy with or without reconstruction in an outpatient community center. Breast Cancer. 2011;18:259–67.

    Article  Google Scholar 

  33. Yilmaz MH, Esen G, Ayarcan Y, Aydoğan F, Ozgüroğlu M, Demir G, et al. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy. Diagn Interv Radiol. 2007;13:13–8.

    PubMed  Google Scholar 

  34. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, American Society of Clinical Oncology, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961–5.

    Article  CAS  Google Scholar 

  35. Lin NU, Thomssen C, Cardoso F, Cameron D, Cufer T, Fallowfield L, European School of Oncology-Metastatic Breast Cancer Task Force, et al. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. Breast. 2013;22:203–10.

    Article  Google Scholar 

  36. Salloum RG, Hornbrook MC, Fishman PA, Ritzwoller DP, O’Keeffe Rossetti MC, et al. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012;118:5644–51.

    Article  Google Scholar 

  37. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, American Society of Clinical Oncology, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287–312.

    Article  CAS  Google Scholar 

  38. Tolaney SM, Winer EP. Follow-up care of patients with breast cancer. Breast Suppl. 2007;2:S45–50.

    Article  Google Scholar 

  39. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2007;25:1074–81.

    Article  Google Scholar 

  40. Smith TJ, American Society of Clinical Oncology. The American Society of Clinical Oncology recommended breast cancer surveillance guidelines can be done in a routine office visit. J Clin Oncol. 2005;23:6807.

    Article  Google Scholar 

  41. Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43:592–9.

    Article  Google Scholar 

  42. Coleman SJ, Rubens RD. The clinical course of bone metastasis from breast cancer. Br J Cancer. 1987;55:61–6.

    Article  CAS  Google Scholar 

  43. Crippa F, Seregni E, Agresti R, Bombardieri E, Buraggi GL. Bone scintigraphy in breast cancer: a ten years follow up study. J Nucl Biol Med. 1993;37:57–61.

    CAS  PubMed  Google Scholar 

  44. Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Nucl Med Commun. 2012;33:591–6.

    Article  Google Scholar 

  45. Murakami R, Kumita S, Yoshida T, Ishihara K, Kiriyama T, Hakozaki K, et al. FDG-PET/CT in the diagnosis of recurrent breast cancer. Acta Radiol. 2012;53:12–6.

    Article  Google Scholar 

  46. Hodgson NC, Gulenchyn KY. Is there a role for positron emission tomography in breast cancer staging? J Clin Oncol. 2008;26:712–20.

    Article  Google Scholar 

  47. Isasi CR, Moadel RM, Blaufox MD. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat. 2005;90:105–12.

    Article  CAS  Google Scholar 

  48. Granziera E, Guglieri I, Del Bianco P, Capovilla E, Dona’ B, Ciccarese AA, et al. A multidisciplinary approach to improve preoperative understanding and reduce anxiety: a randomised study. Eur J Anaesthesiol. 2013;30:734–42.

    Article  Google Scholar 

  49. Rajan S, Foreman J, Wallis MG, Caldas C, Britton P. Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended? Br J Cancer. 2013;108:2442–7.

    Article  CAS  Google Scholar 

  50. Taylor C, Shewbridge A, Harris J, Green JS. Benefits of multidisciplinary teamwork in the management of breast cancer. Breast Cancer (Dove Med Press). 2013;5:79–85.

    Google Scholar 

  51. Bimes J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14:1718–29.

    Article  Google Scholar 

  52. Perz J, Ussher J, Gilbert E. Loss, uncertainty, or acceptance: subjective experience of changes to fertility after breast cancer. Eur J Cancer Care (Engl). 2014;23:514–22.

    Article  CAS  Google Scholar 

  53. Munster PN. Fertility preservation and breast cancer: a complex problem. Oncology (Williston Park). 2013;27:533–9.

    Google Scholar 

  54. Sinha G. Pregnancy after breast cancer appears safe. J Natl Cancer Inst. 2012;104:725–6.

    Article  Google Scholar 

  55. Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Breast International Group-North American Breast Cancer Group Endocrine Working Group, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011;129:309–17.

    Article  Google Scholar 

  56. Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47:74–83.

    Article  Google Scholar 

  57. Kranick JA, Schaefer C, Rowell S, Desai M, Petrek JA, Hiatt RA, et al. Is pregnancy after breast cancer safe? Breast J. 2010;16:404–11.

    PubMed  PubMed Central  Google Scholar 

  58. de Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD. Pregnancy after breast cancer. A comprehensive review. J Surg Oncol. 2010;101:534–42.

    Article  Google Scholar 

  59. Peled R, Carmil D, Siboni-Samocha O, Shoham-Vardi I. Breast cancer, psychological distress and life events among young women. BMC Cancer. 2008;8:245.

    Article  Google Scholar 

  60. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104:386–405.

    Article  Google Scholar 

  61. Zainal NZ, Nik-Jaafar NR, Baharudin A, Sabki ZA, Ng CG. Prevalence of depression in breast cancer survivors: a systematic review of observational studies. Asian Pac J Cancer Prev. 2013;14:2649–56.

    Article  Google Scholar 

  62. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34:611–35.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Breast Disease, Department of General Surgery, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey

    Varol Çelik

  2. Department of Medical Education, Biruni School of Medicine, Biruni University, Istanbul, Turkey

    Tümay Aydoğan

  3. Comprehensive Breast Center, Hallmark Health Medical Associates, Stoneham, MA, USA

    Tümay Aydoğan

  4. Department of Radiology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey

    Mehmet Halit Yilmaz

  5. Department of General Surgery, Osmangazi Medical School, Eskişehir Osmangazi University, Eskişehir, Turkey

    Nejdet Fatih Yaşar

  6. Department of General Surgery, Surgery Department, Istanbul University Medical Faculty, Istanbul Medical School, Istanbul, Turkey

    Mahmut Müslümanoğlu

Authors
  1. Varol Çelik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tümay Aydoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehmet Halit Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nejdet Fatih Yaşar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mahmut Müslümanoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oncology Institute, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Adnan Aydiner

  2. Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Abdullah Igci

  3. Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Magee-Women’s Hospital of UPMC, Pittsburgh, PA, USA

    Atilla Soran

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Çelik, V., Aydoğan, T., Yilmaz, M.H., Yaşar, N.F., Müslümanoğlu, M. (2019). Surveillance of Patients Following Primary Therapy. In: Aydiner, A., Igci, A., Soran, A. (eds) Breast Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-16792-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16792-9_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16791-2

  • Online ISBN: 978-3-030-16792-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation